Durvalumab vs Spironolactone

## Durvalumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Spironolactone**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Spironolactone**: Mineralocorticoid receptor antagonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Spironolactone — 1.4 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Spironolactone — C24H32O4S.

**Molecular Weight**: Durvalumab — N/A; Spironolactone — 416.5740 g/mol.

**Type**: Durvalumab — Antibody; Spironolactone — Small molecule.